Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice
2011 ◽
Vol 216
(2)
◽
pp. 313-320
◽
2012 ◽
Vol 32
(2)
◽
pp. 273-280
◽
1997 ◽
Vol 94
(9)
◽
pp. 4642-4646
◽